Viewing Study NCT07304258


Ignite Creation Date: 2026-03-26 @ 3:18 PM
Ignite Modification Date: 2026-03-31 @ 1:56 AM
Study NCT ID: NCT07304258
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-26
First Post: 2025-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10
Sponsor: Hebei Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module